Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

被引:587
作者
Horai, R
Saijo, S
Tanioka, M
Nakae, S
Sudo, K
Okahara, A
Ikuse, T
Asano, M
Iwakura, Y
机构
[1] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan
[2] Santen Pharmaceut Co Ltd, Dev Res Labs, Osaka 5338651, Japan
关键词
IL-1 receptor antagonist; rheumatoid arthritis; autoimmunity; cytokine; animal model;
D O I
10.1084/jem.191.2.313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-1 is a proinflammatory cytokine that plays important roles in inflammation, host defense, and the neuro-immuno-endocrine network. IL-1 receptor antagonist (ra) is an endogenous inhibitor of IL-1 and is supposed to regulate IL-1 activity. However, its pathophysiological roles in a body remain largely unknown. To elucidate the roles of IL-1ra, IL-1ra-deficient mice were produced by gene-targeting, and pathology was analyzed on different genetic backgrounds. We found that all of the mice on a BALB/cA background, but not those on a C57BL/6J background, spontaneously developed chronic inflammatory polyarthropathy. Histopathology showed marked synovial and periarticular inflammation, with articular erosion caused by invasion of granulation tissues closely resembling that of rheumatoid arthritis in hu mans. Moreover, elevated levels of antibodies against immunoglobulins, type II collagen, and double-stranded DNA were detected in these mice, suggesting development of autoimmunity. Proinflammatory cytokines such as IL-1 beta, IL-6, and tumor necrosis factor alpha were overexpressed in the joints, indicating regulatory roles of IL-1ra in the cytokine network. We thus show that IL-1ra gene deficiency causes autoimmunity and joint-specific inflammation and suggest that IL-1ra is important in maintaining homeostasis of the immune system, Possible involvement of IL-1ra gene deficiency in RA will be discussed.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 39 条
[1]   Interleukin-1 receptor antagonist: Role in biology [J].
Arend, WP ;
Malyak, M ;
Guthridge, CJ ;
Gabay, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :27-55
[2]   INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLAKEMORE, AIF ;
TARLOW, JK ;
CORK, MJ ;
GORDON, C ;
EMERY, P ;
DUFF, GW .
ARTHRITIS AND RHEUMATISM, 1994, 37 (09) :1380-1385
[3]   PURIFICATION, CLONING, EXPRESSION AND BIOLOGICAL CHARACTERIZATION OF AN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN [J].
CARTER, DB ;
DEIBEL, MR ;
DUNN, CJ ;
TOMICH, CSC ;
LABORDE, AL ;
SLIGHTOM, JL ;
BERGER, AE ;
BIENKOWSKI, MJ ;
SUN, FF ;
MCEWAN, RN ;
HARRIS, PKW ;
YEM, AW ;
WASZAK, GA ;
CHOSAY, JG ;
SIEU, LC ;
HARDEE, MM ;
ZURCHERNEELY, HA ;
REARDON, IM ;
HEINRIKSON, RL ;
TRUESDELL, SE ;
SHELLY, JA ;
EESSALU, TE ;
TAYLOR, BM ;
TRACEY, DE .
NATURE, 1990, 344 (6267) :633-638
[4]   DYSREGULATION OF THE IN-VIVO PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN PATIENTS WITH RHEUMATOID-ARTHRITIS - PATHOGENETIC IMPLICATIONS [J].
CHIKANZA, IC ;
ROUXLOMBARD, P ;
DAYER, JM ;
PANAYI, GS .
ARTHRITIS AND RHEUMATISM, 1995, 38 (05) :642-648
[5]  
CHOMARAT P, 1995, J IMMUNOL, V154, P1432
[6]  
CLAY FE, 1994, HUM GENET, V94, P407
[7]   INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4 [J].
COLOTTA, F ;
RE, F ;
MUZIO, M ;
BERTINI, R ;
POLENTARUTTI, N ;
SIRONI, M ;
GIRI, JG ;
DOWER, SK ;
SIMS, JE ;
MANTOVANI, A .
SCIENCE, 1993, 261 (5120) :472-475
[8]   ARTHRITIS IN RATS AFTER SYSTEMIC INJECTION OF STREPTOCOCCAL CELLS OR CELL-WALLS [J].
CROMARTIE, WJ ;
CRADDOCK, JG ;
SCHWAB, JH ;
ANDERLE, SK ;
YANG, CH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (06) :1585-1602
[9]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[10]  
Durum Scott K., 1993, P801